Phoenixville, PA, United States of America

Robert Scott Cheeseman


Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 179(Granted Patents)


Location History:

  • Newtown Square, PA (US) (2000)
  • Phoenixville, PA (US) (1993 - 2002)

Company Filing History:


Years Active: 1993-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Robert Scott Cheeseman

Introduction

Robert Scott Cheeseman is a notable inventor based in Phoenixville, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating various mental health and gastrointestinal disorders. With a total of 3 patents, Cheeseman's work has the potential to impact many lives.

Latest Patents

One of Cheeseman's latest patents is for 1N-alkyl-N-arylpyrimidinamines and derivatives thereof. This invention provides novel compounds and pharmaceutical compositions that can be used in the treatment of affective disorders, anxiety, depression, post-traumatic stress disorders, eating disorders, supranuclear palsy, irritable bowel syndrome, immune suppression, Alzheimer's disease, gastrointestinal diseases, anorexia nervosa, drug and alcohol withdrawal symptoms, drug addiction, inflammatory disorders, and fertility problems. The compounds are defined by a specific formula, wherein various components are detailed in the patent documentation.

Career Highlights

Throughout his career, Cheeseman has worked with prominent companies in the pharmaceutical industry, including DuPont Pharmaceuticals Company and the DuPont Merck Pharmaceutical Company. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Cheeseman has collaborated with notable professionals in his field, including Paul E. Aldrich and Argyrios Georgios Arvanitis. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.

Conclusion

Robert Scott Cheeseman's contributions to pharmaceutical innovations demonstrate his commitment to improving health outcomes through scientific research. His patents reflect a deep understanding of complex medical issues and a dedication to finding effective solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…